| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 6.97e-07 | 37 | 172 | 6 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B ABCA12 SMARCAL1 MYO1B ZNFX1 CHD3 AK9 ZRANB3 STARD9 IGHMBP2 CHD5 SMARCA2 CDC6 KIF13A DDX39A DNAH6 SMC1B HELLS | 6.24e-06 | 614 | 172 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | helicase activity | SMARCAL1 ZNFX1 CHD3 ZRANB3 IGHMBP2 CHD5 SMARCA2 DDX39A HELLS | 9.47e-06 | 158 | 172 | 9 | GO:0004386 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.17e-04 | 127 | 172 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | cadherin binding | BZW2 SPTAN1 CAPG OBSCN MYO1B CC2D1A ACVR1 PROM1 MRTFB SH3GLB1 CGN | 1.78e-04 | 339 | 172 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.60e-04 | 262 | 172 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.56e-04 | 118 | 172 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 7.25e-04 | 5 | 172 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | ATP-dependent DNA/DNA annealing activity | 7.25e-04 | 5 | 172 | 2 | GO:0036310 | |
| GeneOntologyCellularComponent | midbody | 1.00e-04 | 222 | 173 | 9 | GO:0030496 | |
| GeneOntologyCellularComponent | NuRD complex | 3.48e-04 | 17 | 173 | 3 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 3.48e-04 | 17 | 173 | 3 | GO:0090545 | |
| GeneOntologyCellularComponent | nuclear replication fork | 3.97e-04 | 42 | 173 | 4 | GO:0043596 | |
| Domain | SNF2_N | 3.62e-07 | 32 | 168 | 6 | IPR000330 | |
| Domain | SNF2_N | 3.62e-07 | 32 | 168 | 6 | PF00176 | |
| Domain | P-loop_NTPase | KIF21B ABCA12 SMARCAL1 APAF1 MYO1B CARD10 ZNFX1 CHD3 AK9 ZRANB3 TRIM23 STARD9 IGHMBP2 CHD5 SMARCA2 CARD11 CDC6 KIF13A DDX39A DNAH6 MYO16 GNL3 SMC1B HELLS | 6.25e-07 | 848 | 168 | 24 | IPR027417 |
| Domain | DEXDc | 6.37e-06 | 109 | 168 | 8 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.82e-06 | 110 | 168 | 8 | IPR014001 | |
| Domain | - | ABCA12 SMARCAL1 APAF1 CARD10 ZNFX1 CHD3 AK9 ZRANB3 TRIM23 IGHMBP2 CHD5 SMARCA2 CARD11 CDC6 DDX39A DNAH6 GNL3 SMC1B HELLS | 4.35e-05 | 746 | 168 | 19 | 3.40.50.300 |
| Domain | Helicase_C | 5.15e-05 | 107 | 168 | 7 | PF00271 | |
| Domain | HELICc | 5.15e-05 | 107 | 168 | 7 | SM00490 | |
| Domain | Helicase_C | 5.47e-05 | 108 | 168 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 5.80e-05 | 109 | 168 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.80e-05 | 109 | 168 | 7 | PS51192 | |
| Domain | CHD_N | 2.40e-04 | 3 | 168 | 2 | IPR012958 | |
| Domain | CHD_C2 | 2.40e-04 | 3 | 168 | 2 | IPR012957 | |
| Domain | CHDCT2 | 2.40e-04 | 3 | 168 | 2 | PF08074 | |
| Domain | CHDNT | 2.40e-04 | 3 | 168 | 2 | PF08073 | |
| Domain | DUF1086 | 2.40e-04 | 3 | 168 | 2 | IPR009462 | |
| Domain | DUF1087 | 2.40e-04 | 3 | 168 | 2 | IPR009463 | |
| Domain | DUF1087 | 2.40e-04 | 3 | 168 | 2 | PF06465 | |
| Domain | DUF1086 | 2.40e-04 | 3 | 168 | 2 | PF06461 | |
| Domain | DUF1087 | 2.40e-04 | 3 | 168 | 2 | SM01147 | |
| Domain | DUF1086 | 2.40e-04 | 3 | 168 | 2 | SM01146 | |
| Domain | Spectrin_alpha_SH3 | 3.00e-04 | 15 | 168 | 3 | IPR013315 | |
| Pubmed | RELCH DNAJC13 ZFYVE16 BZW2 SPTAN1 PSMB2 MYO1B PPP6R1 USP46 TEX10 KIAA1671 GTF2E1 DUSP29 SLC4A1AP CCDC47 CTR9 PRIM2 SVIL SYNE2 PES1 CGN CRYBG3 COIL TP53BP2 HELLS | 1.11e-10 | 1049 | 174 | 25 | 27880917 | |
| Pubmed | DNAJC13 ZFYVE16 BCORL1 USP24 TNIP1 RNF40 CHD3 PPP6R1 MBIP LIN9 KIAA1671 MRTFB CRYBG3 MRTFA TP53BP2 | 3.61e-09 | 418 | 174 | 15 | 34709266 | |
| Pubmed | SPTAN1 PSMB2 BCORL1 MYO1B TNIP1 CC2D1A CHD3 PPP6R1 USP46 TEX10 MBIP LIN9 GADD45GIP1 KIAA1671 KANSL3 FUBP1 CHD5 SVIL SYNE2 PES1 SMARCA2 TMED9 TAF1L GNL3 HELLS SENP5 | 1.30e-08 | 1429 | 174 | 26 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG DNAJC13 GIT1 ZC3H13 SPTAN1 USP24 CHD3 ADCY6 KANSL3 SLC4A1AP BAZ2A CTR9 TKT FUBP1 SVIL SMARCA2 OXSR1 COIL MRTFA | 1.41e-08 | 774 | 174 | 19 | 15302935 |
| Pubmed | MTA2 MAN2A2 RPS6KA3 SPTAN1 SMARCAL1 TASP1 MYO1B CC2D1A CHD3 RSRC2 TEX10 GADD45GIP1 KANSL3 LUC7L TFB1M CCDC47 TKT STARD9 SVIL PES1 CGN LRRC8A TMED9 COIL GNL3 | 2.45e-08 | 1371 | 174 | 25 | 36244648 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 MTA2 SYNRG MAN2A2 UBE3B KIAA0319L OBSCN TASP1 CC2D1A CARD10 RNF40 SRGAP2 PPP6R1 REV3L KANSL3 MSX2 ZGPAT INF2 CHD5 PREX1 PPP1R16A ATPAF2 | 4.02e-08 | 1105 | 174 | 22 | 35748872 |
| Pubmed | SPTAN1 CNTRL GATB MYO1B CHD3 EPX TEX10 CEP128 ADCY6 DNAJC10 RDH11 CCDC47 CTR9 TKT STARD9 FUBP1 CHD5 SYNE2 PES1 ERC2 DDX39A CEP57 DNAH6 PREX1 ATPAF2 | 6.47e-08 | 1442 | 174 | 25 | 35575683 | |
| Pubmed | 8.57e-08 | 153 | 174 | 9 | 10718198 | ||
| Pubmed | FAM184A DNAJC13 ZC3H13 SPTAN1 MTERF3 PSMB2 APAF1 GATB TNIP1 CC2D1A PPP6R1 FAF2 DNAJC10 SLC4A1AP INF2 BAZ2A CCDC47 CLMN CTR9 SYNE2 PES1 CRYBG3 TMX3 GNL3 HELLS | 1.16e-07 | 1487 | 174 | 25 | 33957083 | |
| Pubmed | 2.25e-07 | 225 | 174 | 10 | 12168954 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MTA2 SYNRG ZFYVE16 MYO1B CC2D1A CHD3 SRGAP2 PPP6R1 KIAA1671 GTF2E1 MRTFB BAZ2A CLMN TKT PES1 COIL GNL3 TP53BP2 HELLS | 2.62e-07 | 934 | 174 | 19 | 33916271 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CCP110 SYNRG GIT1 BCORL1 TBC1D2B MYO1B TNIP1 RNF40 PPP6R1 KIAA1671 KANSL3 MRTFB CTR9 ERC2 CRYBG3 | 3.12e-07 | 588 | 174 | 15 | 38580884 |
| Pubmed | NPC1 ZC3H13 RPS6KA3 CAPG CNTRL OBSCN CHD3 SRGAP2 ZRANB3 TAOK3 INF2 CLMN CTR9 PGAP1 HSD3B2 TMX3 KIF13A DDX39A ANKRD40 MRTFA | 5.77e-07 | 1084 | 174 | 20 | 11544199 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ZFYVE16 BZW2 SPTAN1 CAPG MYO1B CC2D1A SRGAP2 KIAA1671 MRTFB SH3GLB1 CLMN SVIL CGN TP53BP2 | 1.10e-06 | 565 | 174 | 14 | 25468996 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 DNAJC13 SPTAN1 PSMB2 MYO1B TEX10 ZGPAT FAF2 TFB1M RDH11 INF2 BAZ2A CCDC47 CTR9 TKT FUBP1 PRIM2 PES1 SMARCA2 DDX39A GNL3 TP53BP2 | 1.24e-06 | 1353 | 174 | 22 | 29467282 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABAT DNAJC13 CACNA2D2 OBSCN CHD3 SRGAP2 KIAA1671 KANSL3 LUC7L MRTFB PLXDC2 RDH11 INF2 CLMN EFHD1 TGFBRAP1 FUBP1 SETBP1 TBCK SMARCA2 OXSR1 TMX3 GNL3 | 1.66e-06 | 1489 | 174 | 23 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 SYNRG GIT1 SPTAN1 CC2D1A SRGAP2 KIAA1671 LUC7L STOX2 CLMN STARD9 SVIL SYNE2 CGN CRYBG3 KIF13A TP53BP2 | 1.73e-06 | 861 | 174 | 17 | 36931259 |
| Pubmed | FAM184A PSMB2 TASP1 SRGAP2 RSRC2 TEX10 LIN9 KIAA1671 ZGPAT MRTFB TFB1M SLC4A1AP BAZ2A CCDC47 CTR9 EFHD1 IGHMBP2 PES1 SMARCA2 TMED9 TAF1L PREX1 GNL3 | 1.82e-06 | 1497 | 174 | 23 | 31527615 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GIT1 SPTAN1 PSMB2 USP24 LYSMD2 CC2D1A RNF40 SRGAP2 PPP6R1 ZGPAT LUC7L GTF2E1 FAF2 DNAJC10 SLC4A1AP CCDC47 CTR9 TKT PRIM2 SYNE2 GNL3 HELLS | 2.57e-06 | 1415 | 174 | 22 | 28515276 |
| Pubmed | MTA2 SMARCAL1 CAPG PSMB2 RNF40 CHD3 TEX10 KANSL3 GTF2E1 CTR9 TKT FUBP1 PRIM2 PES1 SMARCA2 OXSR1 GNL3 HELLS | 3.75e-06 | 1014 | 174 | 18 | 32416067 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | KIF21B DNAJC13 GIT1 BZW2 RPS6KA1 RPS6KA3 SPTAN1 CC2D1A CHD3 PPP6R1 RDH11 INF2 SYNE2 CARD11 KEL DDX39A WWC1 PMAIP1 TP53BP2 | 4.02e-06 | 1124 | 174 | 19 | 21900206 |
| Pubmed | MTA2 SYNRG SPTAN1 USP24 TNIP1 CC2D1A MBIP KIAA1671 MRTFB BAZ2A CGN COIL TP53BP2 | 4.42e-06 | 549 | 174 | 13 | 38280479 | |
| Pubmed | KIF21B DNAJC13 GIT1 SPTAN1 ZNFX1 SRGAP2 PPP6R1 TEX10 JAKMIP2 CCDC13 STOX2 SVIL SYNE2 DGKI ERC2 TMED9 TP53BP2 | 7.60e-06 | 963 | 174 | 17 | 28671696 | |
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 9.19e-06 | 56 | 174 | 5 | 9455484 | |
| Pubmed | MTA2 BZW2 CAPG PSMB2 BCORL1 CC2D1A CHD3 RSRC2 LIN9 KANSL3 TAOK3 CTR9 TKT FUBP1 PES1 SMARCA2 DDX39A HELLS | 1.18e-05 | 1103 | 174 | 18 | 34189442 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | MTA2 ZC3H13 MYO1B CHD3 LUC7L CTR9 CHD5 PES1 SMARCA2 COIL DDX39A GNL3 HELLS | 1.24e-05 | 605 | 174 | 13 | 28977666 |
| Pubmed | 1.29e-05 | 60 | 174 | 5 | 34761192 | ||
| Pubmed | MTA2 PSD ABCA12 CHD3 PPP6R1 REV3L RSRC2 ADCY6 GADD45GIP1 KIAA1671 DNAJC10 BAZ2A CHD5 SMARCA2 CRYBG3 TMX3 GNL3 WWC1 | 1.37e-05 | 1116 | 174 | 18 | 31753913 | |
| Pubmed | KIF21B RELCH TBC1D2B RNF40 KANSL3 STOX2 CHD5 SETBP1 LRRC8A OXSR1 TMX3 CEP57 | 1.59e-05 | 529 | 174 | 12 | 14621295 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MTA2 SYNRG RNF40 KANSL3 GTF2E1 SLC4A1AP FUBP1 ERC2 OXSR1 HELLS SENP5 | 1.62e-05 | 444 | 174 | 11 | 34795231 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CCP110 SYNRG ROGDI TBC1D2B TNIP1 CC2D1A ZNFX1 PPP6R1 USP46 LIN9 CRY1 LUC7L MRTFB CTR9 COIL WWC1 MRTFA | 1.99e-05 | 1038 | 174 | 17 | 26673895 |
| Pubmed | 2.10e-05 | 298 | 174 | 9 | 30737378 | ||
| Pubmed | SMARCAL1 BCORL1 USP24 ZNFX1 REV3L GADD45GIP1 FAF2 CCDC47 SYNE2 SMARCA2 TMED9 PREX1 HELLS | 2.17e-05 | 638 | 174 | 13 | 31182584 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | SELP TRIM42 TNIP1 RNF40 ACVR1 MBIP TRIM23 ZGPAT RDH11 TKT DDX39A PMAIP1 TP53BP2 CCDC33 | 2.43e-05 | 742 | 174 | 14 | 26871637 |
| Pubmed | Insertional mutation of the mouse Msx1 homeobox gene by an nlacZ reporter gene. | 2.49e-05 | 2 | 174 | 2 | 9256350 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25967713 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 20620318 | ||
| Pubmed | Ventral abdominal wall dysmorphogenesis of Msx1/Msx2 double-mutant mice. | 2.49e-05 | 2 | 174 | 2 | 15803476 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 7537232 | ||
| Pubmed | Comparison of MSX-1 and MSX-2 suggests a molecular basis for functional redundancy. | 2.49e-05 | 2 | 174 | 2 | 8861098 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 8660900 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 19716794 | ||
| Pubmed | The RSK family of kinases: emerging roles in cellular signalling. | 2.49e-05 | 2 | 174 | 2 | 18813292 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 26625210 | ||
| Pubmed | Smarcal1 and Zranb3 Protect Replication Forks from Myc-Induced DNA Replication Stress. | 2.49e-05 | 2 | 174 | 2 | 30610086 | |
| Pubmed | Myocardin related transcription factors are required for coordinated cell cycle progression. | 2.49e-05 | 2 | 174 | 2 | 23656782 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 8101167 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 14728799 | ||
| Pubmed | MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants. | 2.49e-05 | 2 | 174 | 2 | 20338973 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 23853104 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 26498848 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 28461333 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 12944485 | ||
| Pubmed | [Induction phenomena during vertebrate limb development and homeo box gene expression]. | 2.49e-05 | 2 | 174 | 2 | 8099267 | |
| Pubmed | Myocardin-related transcription factors are required for skeletal muscle development. | 2.49e-05 | 2 | 174 | 2 | 27385017 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17494629 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 18442049 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 31221479 | ||
| Pubmed | Position-dependent expression of two related homeobox genes in developing vertebrate limbs. | 2.49e-05 | 2 | 174 | 2 | 1677742 | |
| Pubmed | Myocardin-related transcription factors are required for cardiac development and function. | 2.49e-05 | 2 | 174 | 2 | 26386146 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 9142497 | ||
| Pubmed | MSX-1 gene expression and regulation in embryonic palatal tissue. | 2.49e-05 | 2 | 174 | 2 | 9870533 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 1358591 | ||
| Pubmed | Cloning and evolutionary analysis of msh-like homeobox genes from mouse, zebrafish and ascidian. | 2.49e-05 | 2 | 174 | 2 | 1673109 | |
| Pubmed | Differential impact of MSX1 and MSX2 homeogenes on mouse maxillofacial skeleton. | 2.49e-05 | 2 | 174 | 2 | 18769023 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 32711446 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17714703 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25889895 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17654563 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 28623279 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 34782005 | ||
| Pubmed | Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. | 2.49e-05 | 2 | 174 | 2 | 10910076 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 29335431 | ||
| Pubmed | The Msh-like homeobox genes define domains in the developing vertebrate eye. | 2.49e-05 | 2 | 174 | 2 | 1682128 | |
| Pubmed | Rescue of the limb deformity in hammertoe mutant mice by retinoic acid-induced cell death. | 2.49e-05 | 2 | 174 | 2 | 9097019 | |
| Pubmed | The function and evolution of Msx genes: pointers and paradoxes. | 2.49e-05 | 2 | 174 | 2 | 7482767 | |
| Pubmed | Sequence and expression of chicken and mouse rsk: homologs of Xenopus laevis ribosomal S6 kinase. | 2.49e-05 | 2 | 174 | 2 | 2779569 | |
| Pubmed | NPC1 MTA2 DNAJC13 GIT1 BZW2 CNTRL PSMB2 CC2D1A RNF40 DNAJC10 CCDC47 IGHMBP2 CHD5 PES1 LRRC8A COIL DDX39A GNL3 | 2.51e-05 | 1168 | 174 | 18 | 19946888 | |
| Pubmed | MTA2 ZC3H13 SPTAN1 USP24 MYO1B TEX10 BAZ2A SYNE2 PES1 CGN SMARCA2 COIL GNL3 | 2.76e-05 | 653 | 174 | 13 | 22586326 | |
| Pubmed | MTA2 SPTAN1 CNTRL CC2D1A CARD10 RNF40 NUDT13 RDH11 FUBP1 SYNE2 KIF13A DDX39A WWC1 MRTFA | 2.89e-05 | 754 | 174 | 14 | 35906200 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.32e-05 | 316 | 174 | 9 | 31665637 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MTA2 ZFYVE16 BZW2 RPS6KA1 RPS6KA3 PSMB2 CC2D1A PPP6R1 FAF2 DNAJC10 DUSP29 CTR9 TKT OXSR1 TMX3 WWC1 | 3.40e-05 | 974 | 174 | 16 | 28675297 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MTA2 ZC3H13 RPS6KA3 USP24 KANSL3 LUC7L TAOK3 BAZ2A CCDC47 CTR9 TKT FUBP1 PES1 SMARCA2 TMED9 OXSR1 COIL DDX39A GNL3 | 3.67e-05 | 1318 | 174 | 19 | 30463901 |
| Pubmed | MTA2 BZW2 RPS6KA3 SPTAN1 PSMB2 MYO1B CARD10 PPP6R1 KIAA1671 LUC7L FAF2 DNAJC10 RDH11 INF2 CCDC47 SYNE2 PES1 TMED9 TMX3 HELLS | 3.81e-05 | 1440 | 174 | 20 | 30833792 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DNAJC13 SPTAN1 CAPG USP24 CARD10 CHD3 LUC7L FUBP1 SMARCA2 OXSR1 DDX39A HELLS | 4.04e-05 | 582 | 174 | 12 | 20467437 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MTA2 RELCH GIT1 BZW2 RPS6KA1 RPS6KA3 SPTAN1 PSMB2 USP24 GTF2E1 CHMP4A SH3GLB1 CTR9 FUBP1 PRIM2 PES1 OXSR1 KIF13A DDX39A ANKRD40 | 4.40e-05 | 1455 | 174 | 20 | 22863883 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B TBC1D2B OBSCN AK9 TEX10 RYR3 TAOK3 DNAJC10 SLC4A1AP IGHMBP2 HELLS | 4.52e-05 | 497 | 174 | 11 | 36774506 |
| Pubmed | 4.62e-05 | 187 | 174 | 7 | 26460568 | ||
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 4.75e-05 | 331 | 174 | 9 | 19490893 | |
| Pubmed | MTERF3 FASTKD1 BCORL1 CARD10 SRGAP2 SLC4A1AP INF2 CCDC47 CLMN SVIL DGKI TMX3 TAF1L | 4.77e-05 | 689 | 174 | 13 | 36543142 | |
| Pubmed | 4.86e-05 | 332 | 174 | 9 | 25693804 | ||
| Pubmed | CCP110 ZC3H13 RPS6KA3 USP24 TNIP1 CC2D1A CTR9 FUBP1 COIL KIF13A MRTFA | 5.03e-05 | 503 | 174 | 11 | 16964243 | |
| Pubmed | 5.09e-05 | 334 | 174 | 9 | 30425250 | ||
| Pubmed | MTA2 SPTAN1 MYO1B MBIP GTF2E1 MRTFB SLC4A1AP INF2 FUBP1 PRIM2 MRTFA | 5.31e-05 | 506 | 174 | 11 | 30890647 | |
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 5.36e-05 | 15 | 174 | 3 | 35695185 | |
| Pubmed | 5.36e-05 | 131 | 174 | 6 | 34551306 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | BZW2 GATB RSRC2 GTF2E1 FAF2 CCDC47 PRIM2 OXSR1 CDC6 TMX3 COIL CEP57 GNL3 | 5.93e-05 | 704 | 174 | 13 | 32994395 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MTA2 MYO1B CHD3 TEX10 GADD45GIP1 KIAA1671 LUC7L FUBP1 SVIL SYNE2 PES1 CGN TMED9 COIL GNL3 HELLS | 6.14e-05 | 1024 | 174 | 16 | 24711643 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZRANB3 KIAA1671 MRTFB FAF2 CHD5 SETBP1 SMIM34 OXSR1 MRTFA TP53BP2 | 6.70e-05 | 430 | 174 | 10 | 35044719 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | FAM184A GIT1 BZW2 DTX3 SMARCAL1 CAPG APAF1 CC2D1A MBIP ZGPAT DNAJC10 KIF13A WWC1 MRTFA HELLS | 6.96e-05 | 925 | 174 | 15 | 28986522 |
| Interaction | RAB4A interactions | NPC1 SYNRG RELCH DNAJC13 ZFYVE16 RPS6KA1 SPTAN1 CAPG KIAA0319L TBC1D2B CC2D1A FAF2 INF2 CCDC47 TKT SYNE2 KIF13A | 3.20e-07 | 457 | 169 | 17 | int:RAB4A |
| Interaction | HDAC1 interactions | MTA2 DNAJC13 ZFYVE16 SPTAN1 USP24 TNIP1 RNF40 CHD3 PPP6R1 CEP128 MBIP LIN9 CRY1 KIAA1671 MSX2 ZGPAT MRTFB BAZ2A CCDC47 CHD5 SYNE2 SMARCA2 CRYBG3 COIL MRTFA TP53BP2 HELLS | 5.57e-07 | 1108 | 169 | 27 | int:HDAC1 |
| Interaction | ENTR1 interactions | FAM184A GIT1 CNTRL TBC1D2B TNIP1 CC2D1A CHD3 CEP128 KIAA1671 TP53BP2 | 4.35e-06 | 188 | 169 | 10 | int:ENTR1 |
| Interaction | YWHAH interactions | KIF21B CCP110 SYNRG GIT1 RPS6KA1 ZC3H13 RPS6KA3 SPTAN1 CNTRL CC2D1A SRGAP2 USP46 CEP128 CRY1 KIAA1671 STOX2 TFB1M CLMN STARD9 SVIL SYNE2 CGN CRYBG3 WWC1 TP53BP2 | 5.47e-06 | 1102 | 169 | 25 | int:YWHAH |
| Interaction | PHF21A interactions | DNAJC13 ZFYVE16 BCORL1 USP24 TNIP1 RNF40 PPP6R1 MBIP KIAA1671 MRTFB CRYBG3 MRTFA TP53BP2 | 6.78e-06 | 343 | 169 | 13 | int:PHF21A |
| Interaction | KDM1A interactions | MTA2 DNAJC13 ZFYVE16 BCORL1 USP24 TNIP1 CARD10 RNF40 CHD3 PPP6R1 LIN9 KIAA1671 MRTFB SLC4A1AP PRIM2 SMARCA2 CRYBG3 COIL CEP57 MRTFA TP53BP2 CCDC33 | 1.33e-05 | 941 | 169 | 22 | int:KDM1A |
| Interaction | SYNE3 interactions | CCP110 SYNRG TNIP1 CC2D1A CARD10 CEP128 KIAA1671 DNAJC10 CCDC47 CLMN SYNE2 CRYBG3 TMX3 TP53BP2 | 2.37e-05 | 444 | 169 | 14 | int:SYNE3 |
| Interaction | PFN1 interactions | SYNRG DNAJC13 SPTAN1 TBC1D2B TNIP1 SRGAP2 TRIM23 KIAA1671 INF2 TKT CHD5 SYNE2 CRYBG3 KIF13A MRTFA | 2.65e-05 | 509 | 169 | 15 | int:PFN1 |
| Interaction | NINL interactions | CCP110 FAM184A GIT1 TNIP1 CC2D1A RNF40 CEP128 MBIP KIAA1671 TRPM5 TKT SVIL TP53BP2 CCDC33 | 3.33e-05 | 458 | 169 | 14 | int:NINL |
| Interaction | CEP19 interactions | 5.49e-05 | 157 | 169 | 8 | int:CEP19 | |
| Interaction | CCDC159 interactions | 6.99e-05 | 2 | 169 | 2 | int:CCDC159 | |
| Interaction | LRFN5 interactions | 6.99e-05 | 2 | 169 | 2 | int:LRFN5 | |
| Interaction | RCOR1 interactions | MTA2 DNAJC13 ZFYVE16 SPTAN1 BCORL1 USP24 TNIP1 RNF40 CHD3 PPP6R1 MBIP MRTFB MRTFA TP53BP2 | 7.52e-05 | 494 | 169 | 14 | int:RCOR1 |
| Interaction | CCDC13 interactions | 8.10e-05 | 53 | 169 | 5 | int:CCDC13 | |
| Interaction | CALD1 interactions | 8.34e-05 | 265 | 169 | 10 | int:CALD1 | |
| Interaction | CEP162 interactions | 8.83e-05 | 168 | 169 | 8 | int:CEP162 | |
| Interaction | IL16 interactions | 9.89e-05 | 127 | 169 | 7 | int:IL16 | |
| Interaction | ZNF330 interactions | TRIM42 BCORL1 CHD3 TEX10 GTF2E1 SLC4A1AP CTR9 TKT PES1 COIL GNL3 CCDC33 HELLS | 1.03e-04 | 446 | 169 | 13 | int:ZNF330 |
| Interaction | IFI16 interactions | SPTAN1 OBSCN TNIP1 RNF40 TEX10 LUC7L DNAJC10 SLC4A1AP INF2 BAZ2A TKT IGHMBP2 SVIL PES1 COIL DDX39A GNL3 | 1.09e-04 | 714 | 169 | 17 | int:IFI16 |
| Interaction | HNRNPCL2 interactions | BCORL1 APAF1 TBC1D2B TNIP1 CHD3 TEX10 BAZ2A CTR9 OXSR1 HELLS | 1.10e-04 | 274 | 169 | 10 | int:HNRNPCL2 |
| Interaction | MED4 interactions | KIF21B CCP110 FAM184A GIT1 ZFYVE16 ZC3H13 SPTAN1 CNTRL RNF40 RSRC2 CEP128 PMAIP1 TP53BP2 | 1.13e-04 | 450 | 169 | 13 | int:MED4 |
| Interaction | CRB1 interactions | 1.21e-04 | 12 | 169 | 3 | int:CRB1 | |
| Interaction | CEP63 interactions | 1.37e-04 | 179 | 169 | 8 | int:CEP63 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.13e-05 | 181 | 106 | 8 | 694 | |
| GeneFamily | PHD finger proteins|NuRD complex | 4.15e-05 | 12 | 106 | 3 | 1305 | |
| GeneFamily | Ankyrin repeat domain containing | 5.59e-04 | 242 | 106 | 7 | 403 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 7.09e-04 | 30 | 106 | 3 | 959 | |
| GeneFamily | Gelsolin/villins | 9.32e-04 | 8 | 106 | 2 | 950 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 1.81e-03 | 11 | 106 | 2 | 1156 | |
| GeneFamily | UPF1 like RNA helicases | 1.81e-03 | 11 | 106 | 2 | 1169 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.48e-03 | 46 | 106 | 3 | 622 | |
| Coexpression | GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP | KIF21B RPS6KA3 SRGAP2 ZRANB3 RYR3 DNAJC10 LRFN5 PGAP1 TBCK CARD11 CRYBG3 | 9.37e-08 | 200 | 172 | 11 | M5093 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DNAJC13 ZFYVE16 RPS6KA3 USP24 MYO1B SRGAP2 ACVR1 REV3L CRY1 TAOK3 UBE2G1 FUBP1 PRIM2 SYNE2 SMARCA2 OXSR1 CRYBG3 WWC1 MRTFA TP53BP2 | 9.56e-07 | 856 | 172 | 20 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | DNAJC13 USP24 MYO1B SRGAP2 ACVR1 REV3L CRY1 UBE2G1 FUBP1 PRIM2 SMARCA2 OXSR1 WWC1 TP53BP2 | 2.66e-06 | 466 | 172 | 14 | M13522 |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP | 3.85e-05 | 190 | 172 | 8 | M8021 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN | 4.97e-05 | 197 | 172 | 8 | M7255 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_UP | 5.34e-05 | 199 | 172 | 8 | M3164 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 5.34e-05 | 199 | 172 | 8 | M3191 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 5.34e-05 | 199 | 172 | 8 | M3197 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN | 5.53e-05 | 200 | 172 | 8 | M7162 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 5.53e-05 | 200 | 172 | 8 | M8485 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN | 5.53e-05 | 200 | 172 | 8 | M7878 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.52e-07 | 194 | 173 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 174 | 173 | 7 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 174 | 173 | 7 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 174 | 173 | 7 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 187 | 173 | 7 | 08f2ecce3c08f35d995187b21bb7407a99dee4c2 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-epithelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 187 | 173 | 7 | 939a068ac0913b9eeb5da4a9cb267d51cb711999 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 187 | 173 | 7 | e02e7f608506b9a48384f07727944f1cb8f7c575 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 193 | 173 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 193 | 173 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.22e-05 | 197 | 173 | 7 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 198 | 173 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.05e-05 | 168 | 173 | 6 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.22e-05 | 169 | 173 | 6 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.22e-05 | 169 | 173 | 6 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 169 | 173 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.40e-05 | 170 | 173 | 6 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 173 | 173 | 6 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 173 | 173 | 6 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 175 | 173 | 6 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.34e-05 | 175 | 173 | 6 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.54e-05 | 176 | 173 | 6 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.96e-05 | 178 | 173 | 6 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.96e-05 | 178 | 173 | 6 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.87e-05 | 182 | 173 | 6 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 8.36e-05 | 184 | 173 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 8.36e-05 | 184 | 173 | 6 | 22c15ce30171c687ab564f4383ae74d38b759272 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.87e-05 | 186 | 173 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 8.87e-05 | 186 | 173 | 6 | 701eea0016d69f0f9d29b613948f91239096e6c7 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.87e-05 | 186 | 173 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-05 | 187 | 173 | 6 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 188 | 173 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 188 | 173 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 188 | 173 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.41e-05 | 188 | 173 | 6 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 9.41e-05 | 188 | 173 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.41e-05 | 188 | 173 | 6 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.68e-05 | 189 | 173 | 6 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 9.68e-05 | 189 | 173 | 6 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.97e-05 | 190 | 173 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 191 | 173 | 6 | c21e7904e06a5c90176f935f6822dbb5a1aa6755 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-04 | 191 | 173 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 191 | 173 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 191 | 173 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 191 | 173 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.06e-04 | 192 | 173 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.06e-04 | 192 | 173 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 192 | 173 | 6 | 4098b5170c9995718758a082d1b8bcb86d5a289e | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 192 | 173 | 6 | 936028fe851e8dd2b906df0210acc574c017b499 | |
| ToppCell | droplet-Fat-Scat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 192 | 173 | 6 | 62e55ed0d46b2e7b07dc42399972a099576cbc5f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-04 | 192 | 173 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.09e-04 | 193 | 173 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 1.09e-04 | 193 | 173 | 6 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 194 | 173 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.15e-04 | 195 | 173 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 196 | 173 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.18e-04 | 196 | 173 | 6 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 1.22e-04 | 197 | 173 | 6 | 40c8ff067e8242e2ca083ea04cd6026168191a97 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.23e-04 | 124 | 173 | 5 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 198 | 173 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.25e-04 | 198 | 173 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 198 | 173 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 198 | 173 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.25e-04 | 198 | 173 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.25e-04 | 198 | 173 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 199 | 173 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 199 | 173 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.28e-04 | 199 | 173 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 199 | 173 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 199 | 173 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | CV-Moderate-2|CV / Virus stimulation, Condition and Cluster | 1.28e-04 | 199 | 173 | 6 | 2d98424a5247e87f98095c11fb945289092a9d75 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.28e-04 | 199 | 173 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 1.28e-04 | 199 | 173 | 6 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.28e-04 | 199 | 173 | 6 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.28e-04 | 199 | 173 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 200 | 173 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.32e-04 | 200 | 173 | 6 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 200 | 173 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.32e-04 | 200 | 173 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.32e-04 | 200 | 173 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Parenchymal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 200 | 173 | 6 | 4e5b6cb014d9bcb58e13c7511c86c43e27c496e4 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 200 | 173 | 6 | be46efc899d06c55ee297bee3126f69bcdb2048b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.32e-04 | 200 | 173 | 6 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A | 2.52e-06 | 197 | 171 | 10 | 435_DN | |
| Disease | cancer | ROGDI SMARCAL1 CHD3 FAM83C CHMP4A EFHD1 ERC2 SMIM34 KIF13A PREX1 MRTFA | 2.49e-05 | 400 | 172 | 11 | MONDO_0004992 |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | progression free survival, ovarian serous carcinoma | 2.76e-04 | 22 | 172 | 3 | EFO_0004920, EFO_1001516 | |
| Disease | cadherin-7 measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0801438 | |
| Disease | STARGARDT DISEASE 1 (disorder) | 3.34e-04 | 5 | 172 | 2 | C1855465 | |
| Disease | partial thromboplastin time | 3.60e-04 | 24 | 172 | 3 | EFO_0004310 | |
| Disease | torsin-1A-interacting protein 1 measurement | 4.99e-04 | 6 | 172 | 2 | EFO_0802137 | |
| Disease | solute carrier family 22 member 16 measurement | 4.99e-04 | 6 | 172 | 2 | EFO_0802079 | |
| Disease | Stargardt's disease | 4.99e-04 | 6 | 172 | 2 | C0271093 | |
| Disease | Sezary Syndrome | 5.14e-04 | 27 | 172 | 3 | C0036920 | |
| Disease | Developmental Psychomotor Disorders | 6.96e-04 | 7 | 172 | 2 | C0751456 | |
| Disease | Psychomotor Disorders | 6.96e-04 | 7 | 172 | 2 | C0033922 | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 6.96e-04 | 7 | 172 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | Congenital Amaurosis of Retinal Origin | 9.24e-04 | 8 | 172 | 2 | C3540662 | |
| Disease | body shape measurement | 9.24e-04 | 8 | 172 | 2 | EFO_0801227 | |
| Disease | obsolete_red blood cell distribution width | DNAJC13 BZW2 UBE3B AK9 LIN9 OR2M4 ZGPAT LUC7L STAC2 TAOK3 SYNE2 SMARCA2 OXSR1 CEP57 MYO16 GNL3 TMEM40 HELLS | 9.24e-04 | 1347 | 172 | 18 | EFO_0005192 |
| Disease | visual epilepsy (implicated_via_orthology) | 1.02e-03 | 34 | 172 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | Retinal Pigment Epithelial Detachment | 1.18e-03 | 9 | 172 | 2 | C0339546 | |
| Disease | Motor retardation | 1.18e-03 | 9 | 172 | 2 | C0424230 | |
| Disease | Retinal Detachment | 1.79e-03 | 11 | 172 | 2 | C0035305 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.53e-03 | 13 | 172 | 2 | EFO_0802114 | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 2.53e-03 | 13 | 172 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | lifestyle measurement | 2.63e-03 | 235 | 172 | 6 | EFO_0010724 | |
| Disease | triacylglycerol 46:0 measurement | 3.37e-03 | 15 | 172 | 2 | EFO_0010400 | |
| Disease | monoclonal gammopathy | 3.68e-03 | 53 | 172 | 3 | EFO_0000203 | |
| Disease | Tremor, Rubral | 3.84e-03 | 16 | 172 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 3.84e-03 | 16 | 172 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 3.84e-03 | 16 | 172 | 2 | C0278161 | |
| Disease | Leber congenital amaurosis | 3.84e-03 | 16 | 172 | 2 | cv:C0339527 | |
| Disease | Ataxia, Sensory | 3.84e-03 | 16 | 172 | 2 | C0240991 | |
| Disease | Abnormal coordination | 3.84e-03 | 16 | 172 | 2 | C0520966 | |
| Disease | amyloid-beta measurement, Alzheimer's disease biomarker measurement | 3.84e-03 | 16 | 172 | 2 | EFO_0005194, EFO_0006514 | |
| Disease | Ataxia, Truncal | 3.84e-03 | 16 | 172 | 2 | C0427190 | |
| Disease | Small cell carcinoma of lung | 3.88e-03 | 54 | 172 | 3 | C0149925 | |
| Disease | response to tenofovir, creatinine clearance measurement | 4.25e-03 | 112 | 172 | 4 | EFO_0007934, EFO_0009279 | |
| Disease | unipolar depression | LYSMD2 AK9 GRM8 CRB1 KIAA1671 TAOK3 DNAJC10 TKT LRFN5 SVIL SYNE2 SMARCA2 ERC2 CFAP61 DNAH6 | 4.80e-03 | 1206 | 172 | 15 | EFO_0003761 |
| Disease | mean corpuscular hemoglobin concentration | DNAJC13 BZW2 RPS6KA1 MYO1B PPP6R1 LIN9 ZGPAT LUC7L OXSR1 DDX39A CEP57 PREX1 MYO16 PPP1R16A | 5.45e-03 | 1105 | 172 | 14 | EFO_0004528 |
| Disease | response to opioid | 5.47e-03 | 61 | 172 | 3 | EFO_0008541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLAIARLKRTEFKRL | 286 | A8MVM7 | |
| TVKDFRLLKNSRLLS | 1046 | O14727 | |
| SLRKANLDKRLLELF | 206 | Q9Y6E2 | |
| ELREEFSKLQNRTKL | 41 | P26439 | |
| LRSQALELNKRKAVE | 851 | O75150 | |
| RSRDLQLAVDQLKLK | 226 | Q9BWT7 | |
| FIDLRKELRQILASK | 1156 | Q8NHU2 | |
| LRRKKRFEQQLAQTD | 66 | Q9BY43 | |
| NLRKELNDVLTKRAL | 541 | Q6ZU80 | |
| SLLRNQFLTERKKAE | 2056 | Q7Z7A1 | |
| LAENAKLRTELDKNR | 821 | Q8N5R6 | |
| LLDRKVQALKRLADA | 126 | Q9NY47 | |
| NKFLARRFKLLEQAL | 1786 | Q8TDI0 | |
| QRNFILGSLKRVLKD | 2371 | Q68DQ2 | |
| LDSKLRQLLFNKLSA | 841 | Q5T601 | |
| RRFLLTFQREDLEKK | 646 | O43306 | |
| LALVRNRSFSLKNVK | 176 | O00148 | |
| LINESLIKKLRLFFR | 2206 | Q86UK0 | |
| LERQIEKLSKRQLFF | 1086 | Q9UIF9 | |
| DVLKRLKLSSRIFQA | 1701 | Q5H9F3 | |
| LLGVALRKFKRRNQE | 141 | Q04771 | |
| SALKNLQDKIRRLEL | 71 | Q86XR8 | |
| KKLQALSNRLFEELA | 266 | Q9Y2X7 | |
| RTEVKNLNSIRFLAK | 276 | O75879 | |
| TLLRKDKDVARLQDF | 316 | Q6AI12 | |
| LLQLKDREKNAARDS | 671 | Q8NB25 | |
| RNQSDADLEALRKKL | 711 | Q13625 | |
| NLRSFTKIIKRLAEL | 991 | Q6ZP01 | |
| ANRAKLLAKNRQTFL | 441 | O94776 | |
| LVLRLRNSKKELNDI | 436 | O95747 | |
| LRQRLTKNAQDKLEL | 416 | Q8IWT6 | |
| LRLADNFVTNIKRKD | 56 | Q96NI6 | |
| LRKAKETIQALRANL | 211 | Q9P260 | |
| KRALNFLVNEFLLKN | 256 | Q9P260 | |
| LIRELKRFNADNKLL | 366 | Q9NRZ9 | |
| ARKLFDTERLKLLQE | 141 | Q96AA8 | |
| ASQKIGFRLRNLLKL | 101 | Q5TKA1 | |
| LGFIQIREKLDQLRK | 216 | Q9NQ29 | |
| ARDFLQRLDLQIKLS | 176 | Q8IV50 | |
| QRNKDQLIRAAVKFL | 121 | Q8N5M1 | |
| DLTARFENKEALLRK | 286 | Q9BY89 | |
| ALTERLKLNSKRNQL | 391 | Q8IX03 | |
| SLNREKLAVLKRALN | 636 | Q9Y6X6 | |
| FKDALQRARQIAAKI | 31 | Q96AE4 | |
| ELRKQKADFLIFRAL | 866 | Q8IZA0 | |
| LLDKILRQKFFSERE | 501 | P51812 | |
| DDSIRNKLILIARNK | 446 | P80404 | |
| QLRFLKRQDLLNVLA | 221 | Q96A33 | |
| SLRNKEVFRALQKVL | 291 | Q96R27 | |
| RVLKNQDLARKFLNL | 591 | P11678 | |
| KREELFLLQEALRRK | 946 | O75037 | |
| LKRARLADDLNEKIA | 121 | Q9ULH7 | |
| DINLSLRKAKKRAFQ | 101 | P38432 | |
| LQKKALLNEEVARRA | 131 | O95237 | |
| DRQAKELFLLRKTLE | 271 | O15083 | |
| SLRNKDVAAALRKVL | 291 | Q8NGX2 | |
| DIRRILEAAKKLNQS | 286 | O00222 | |
| IELRKALFQLNARDA | 136 | Q86X67 | |
| FRDLFLRALKENKDR | 916 | Q27J81 | |
| SLLGLDIKRQEKNRL | 781 | O15118 | |
| ALLKELIRNKARNRQ | 5841 | Q5VST9 | |
| SLRNKNVKDALKRFL | 291 | Q8NGG1 | |
| AIILNEFRAKLSKAL | 216 | P49643 | |
| NKVLTLFRKAFDQRL | 276 | Q8N9I9 | |
| RFGDKLNFRQKLLNL | 31 | Q13794 | |
| LITIRNAKAAKLSRF | 1541 | Q9C0G6 | |
| NRGFLKQLRELDKQL | 186 | Q68J44 | |
| EALEEKLRNLTFRKQ | 116 | O75912 | |
| QRDKAKNIKDLLRFL | 151 | Q9BQN1 | |
| KFLARRFKLLEQALV | 1791 | Q12873 | |
| KLSAQEKNLLRIRSL | 306 | Q8IYE1 | |
| DLDANLRKLNSRLFV | 61 | Q16526 | |
| QRKEFFAKLRELLLS | 391 | Q53R41 | |
| LNKLEKARLAFSRAL | 211 | Q6PD62 | |
| KARLAFSRALELNSK | 216 | Q6PD62 | |
| FLEGRKKQLLQAALR | 496 | Q6P1N0 | |
| LKGRRLVFDNQLTIK | 91 | Q99741 | |
| FLDNSFEKVKRRLDL | 576 | O43303 | |
| FRASKELKQRFQRLD | 71 | P56937 | |
| AALTAFIKADLRRQK | 481 | Q9UPI3 | |
| DKLERDRLILFLNKL | 906 | O75165 | |
| LLALLRKRFRQKDDG | 791 | P16109 | |
| LKDNKRTCNRFRLLL | 976 | P49641 | |
| LNEARTLFRKNKNLT | 41 | O43325 | |
| ISALKQALLRKSREA | 321 | Q9NS73 | |
| EERRLRQAAFQKLKA | 221 | Q9BUP0 | |
| RSARFQELLQDLEKK | 171 | Q8TAE8 | |
| FKEALLREAELRKQR | 56 | Q9BVP2 | |
| NKILKALQSDRLARL | 141 | Q9P2N6 | |
| KSNILERNKARDLAL | 181 | P40121 | |
| ASSREIRQAFKKLAL | 46 | Q8IXB1 | |
| ALLLFRSNRDVFVKL | 521 | P82279 | |
| RNKTTFVLLRDKVNL | 1571 | Q8TDX9 | |
| LESKLRRLSKDSNNL | 431 | Q9BXL7 | |
| LQLLAQEIRDSKKFL | 131 | P0C7I6 | |
| FKRLVAKSLLNQEIR | 301 | Q9GZK3 | |
| KLRSLINAAQLTKRF | 16 | Q96E29 | |
| FISELLSQLKKLRRL | 126 | Q9NXH3 | |
| SLRNKEVKDALLRAL | 291 | P0C629 | |
| TSQLLALERKFRQKQ | 151 | P35548 | |
| FRQSLAKLREQLVKA | 671 | Q9H1H9 | |
| LLKFDRKQLRSVLNN | 51 | P29083 | |
| KLLRELQARKQAETA | 456 | Q5TCS8 | |
| KLANILFTQELARRL | 206 | Q8TC12 | |
| LKQLQDILKEASLRF | 31 | Q9GZN7 | |
| QEALARRLERAKKLQ | 236 | Q7L4I2 | |
| IRNGFLKLRSILQEK | 376 | Q8IWZ5 | |
| QKADLEAAQRLAKRL | 551 | A5PKW4 | |
| FRLASNILRKNDKSL | 66 | A8MWV9 | |
| ATVELKALRLLNFQR | 376 | P51531 | |
| FSKLNRLKVLILNDN | 156 | Q9H5Y7 | |
| KLDRLETFLRRLNNK | 1266 | O95425 | |
| LFLEDQLKNLKIRTN | 2911 | Q8WXH0 | |
| RQFEEQKQKLRLLSS | 141 | Q9UMZ2 | |
| TAQLLALERKFRQKQ | 181 | P28360 | |
| DADLRRLSLKNAKQL | 1011 | Q8IZX4 | |
| QALNDAKRELRFLLV | 161 | Q96CS3 | |
| LKRRSFLKNDDLIIF | 576 | Q16819 | |
| RKLADSNFKDLRTLL | 191 | O43490 | |
| NRQKALARRAEKLLA | 16 | Q9NZC9 | |
| LRNDFKLVENILAKR | 611 | Q8TCU6 | |
| LADLKRQRAAAKLQR | 456 | Q96I34 | |
| RKCLEELQKRFILNL | 161 | P49721 | |
| KRNLDFLKAVDTNRA | 66 | Q6UX71 | |
| ERKLLQNKRLDLDAA | 161 | Q9Y371 | |
| AALQKERSERIKNLL | 851 | Q9H2K8 | |
| NFLLDLRLTDKIVRK | 36 | Q8WVM0 | |
| RALLTLKNFKHDLIN | 181 | Q75T13 | |
| RLRAEKEQDSLNAKL | 1556 | Q9P2P6 | |
| LKRARLADDLNEKIA | 61 | Q969V6 | |
| IFRLNNIAKALKFLE | 91 | Q96JQ2 | |
| ISLERQNKDLKTRLA | 1021 | Q9P2M7 | |
| ASLARLLKLKREQAA | 686 | Q9NQW8 | |
| QSNRLRAEVFKKQLL | 676 | Q96M02 | |
| AAKDKLSELQLRVRQ | 156 | Q9BVK6 | |
| SILQRLKRIVFDAKS | 351 | Q96JJ7 | |
| REQKQRDFDRKLLLA | 356 | Q15025 | |
| ETQAKLRRLLQKSDL | 636 | Q8WUH2 | |
| LLRLQAEKLLSSAKN | 111 | Q96HI0 | |
| KRRLNLDIILSLFLN | 466 | Q9UK11 | |
| NRNALKALLEFLRKV | 396 | Q5TG30 | |
| SVSRKSLLFDLLQRK | 421 | Q9NZQ8 | |
| NKARKKLQLSLADFR | 21 | O00541 | |
| KLQALKDTANRLRIS | 11 | P29401 | |
| VLFKLSRVNRELSKA | 3106 | O60673 | |
| LRALENLKTVRDKFQ | 1021 | Q8NDV3 | |
| RNVTDFLKRATLKNL | 4151 | Q15413 | |
| RAQLQRRLDKKLSEL | 966 | P38935 | |
| ERDLQRKFEKNLTLL | 811 | Q9P2F5 | |
| RKQKLADSLRLQQLF | 776 | Q13813 | |
| LQETKLQRFKRSLSL | 26 | Q6ZMT1 | |
| NLEKLAERFLAKTRS | 66 | O75044 | |
| ASQLRRLNIKKDDEF | 146 | Q8WWA1 | |
| KRRFRIQKQLLADVA | 306 | Q6UXI7 | |
| KVLVRLSKFLQALAD | 226 | Q9NXF1 | |
| RKLFQSLDISERLKF | 201 | Q8TEA7 | |
| LINRKTDQLVSFLRK | 131 | Q9UPN7 | |
| SEILKQFTLRELRNK | 686 | Q9P2E3 | |
| RKLLFLFRIKEDNER | 81 | Q7Z3V4 | |
| KFISRLRKENDLFDN | 101 | P62068 | |
| ATIRKALRLAKNDIN | 21 | Q9UPU5 | |
| RFRQLDTKLNDLKGL | 1081 | Q7Z2W7 | |
| KELRDALLLIFANKQ | 501 | P36406 | |
| FRNLKALTRLDLSKN | 141 | O60602 | |
| KRKSLQNRDDLQFLA | 941 | Q9Y6X0 | |
| SALLLRRQLAELNKN | 6 | P62253 | |
| RKQDIEFLTKLNLFL | 101 | A0A1B0GUJ8 | |
| FSLAAFKRNKRKLEL | 191 | Q9H6P5 | |
| KFLNKEILELSALRR | 501 | Q9UPU7 | |
| AKRALSLRLFQTEEK | 451 | Q8N5A5 | |
| NKQLALERRQAKLLS | 206 | Q9BVW5 | |
| DNELLRLSLRLFKRK | 1626 | Q5T200 | |
| LRLALREQKDFKITC | 1356 | Q7Z3T8 | |
| FLRLRDAPKSQRKNL | 976 | Q5FWF4 | |
| FQEARRKLSQKLREL | 381 | P23276 | |
| ELLDKILRQKFFSER | 496 | Q15418 | |
| RTLFKLEDLRKQRLE | 691 | O43795 | |
| TFELRKEQQRLKGLI | 561 | Q9BWU0 |